C12N 2750/14022
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2750/14022 (New viral proteins or individual genes, new structural or functional aspects of) appears on 14 US grants and 21 published applications in this corpus.
Search patents in C12N- Granted patents
- 14
- Published applications
- 21
- Assignees
- 22
- Inventors
- 74
- Latest grant
- 24 Sep 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 1 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 2 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 2 | 1 |
| 2013 | 1 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 2 |
| 2016 | 0 | 1 |
| 2017 | 2 | 0 |
| 2018 | 1 | 1 |
| 2019 | 0 | 1 |
| 2020 | 0 | 1 |
| 2021 | 2 | 3 |
| 2022 | 0 | 2 |
| 2023 | 2 | 1 |
| 2024 | 2 | 1 |
| 2025 | 0 | 3 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Recombinant porcine parvovirus antigenic protein and use thereof24 Sep 2024US 12,097,255 B2Bioapplications Inc.
- Insect toxin delivery mediated by a densovirus coat protein25 Jun 2024US 12,016,333 B2Iowa State University Research Foundation, Inc.
- Paramyxoviridae expression system22 Aug 2023US 11,730,805 B2Boehringer Ingelheim Vetmedica GmbH
- Gene therapies for lysosomal disorders28 Mar 2023US 11,613,737 B2Prevail Therapeutics, Inc.
- Insect toxin delivery mediated by a densovirus coat protein12 Oct 2021US 11,140,902 B2Iowa State University Research Foundation, Inc.
- Adeno-associated virus structural plasmid capable of improving adeno-assocaited virus titer26 Feb 2026US 2026/0055427 A1Zhenjiang Probio Biotech Co., Ltd.
- Capsid variants and methods of using the same20 Nov 2025US 2025/0352671 A1Dyno Therapeutics, Inc.
- Compositions and methods for recombinant aav production17 Jul 2025US 2025/0230465 A1REGENXBIO Inc.
- Engineered viral vectors with enhanced packaging capacity and methods of using the same29 May 2025US 2025/0171806 A1Massachusetts Institute of Technology
- Protoparvovirus and tetraparvovirus compositions and methods for gene therapy29 Feb 2024US 2024/0066080 A1Synteny Therapeutics, Inc.
Most cited
By later US patents
- Hairpin MRNA elements and methods for the regulation of protein translation11US 11,034,974 B2University of Florida Research Foundation, Inc. · 2021
- Hairpin mRNA elements and methods for the regulation of protein translation7US 10,006,049 B2University of Florida Research Foundation, Inc. · 2018
- Recombinant multivalent viral vaccine7US 7,087,234 B1Cornell Research Foundation, Inc. · 2006
- Vaccines containing canine parvovirus genetic variants1US 8,227,583 B2The Board of Regents for Oklahoma State University · 2012
- Vaccines containing canine parvovirus genetic variants1US 8,258,274 B2The Board of Regents for Oklahoma State University · 2012